Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 5.79 is 49% below its 5-year average of 11.24, near the low end of its 5-year range (2.77–20.94).
As of the fiscal period ended Tuesday, June 30, 2026. 45.60% above its 12-month average of 3.98.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 5.79.
QUICK RATIO (ACID-TEST)
5.79
QUICK RATIO (ACID-TEST) AVG TTM
3.98
QUICK RATIO (ACID-TEST) AVG 3Y
8.78
QUICK RATIO (ACID-TEST) AVG 5Y
11.24
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+45.60%
CURRENT VS 3Y AVG
-34.08%
CURRENT VS 5Y AVG
-48.51%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.30
median of 827 covered companies
CURRENT VS SECTOR MEDIAN
+75.42%
vs the sector median at left
Cabaletta Bio, Inc.
Market Cap
$319.59M
Quick Ratio (Acid-Test)
5.79
TTM Avg
3.98
3Y Avg
8.78
5Y Avg
11.24
Market Cap
$319.69M
Quick Ratio (Acid-Test)
3.87
TTM Avg
3.84
3Y Avg
4.42
5Y Avg
6.10
Market Cap
$319.85M
Quick Ratio (Acid-Test)
0.34
TTM Avg
1.47
3Y Avg
4.59
5Y Avg
7.40
Market Cap
$321.44M
Quick Ratio (Acid-Test)
2.30
TTM Avg
1.79
3Y Avg
1.49
5Y Avg
1.77
Market Cap
$323.87M
Quick Ratio (Acid-Test)
2.44
TTM Avg
4.94
3Y Avg
7.05
5Y Avg
7.05
Market Cap
$311.49M
Quick Ratio (Acid-Test)
5.45
TTM Avg
6.76
3Y Avg
6.92
5Y Avg
7.12
Market Cap
$303.06M
Quick Ratio (Acid-Test)
12.80
TTM Avg
4.01
3Y Avg
4.01
5Y Avg
4.01
Market Cap
$302.14M
Quick Ratio (Acid-Test)
34.00
TTM Avg
44.34
3Y Avg
25.02
5Y Avg
19.51
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | $319.59M | 5.79 | 3.98 | 8.78 | 11.24 |
| ClearPoint Neuro, Inc. (CLPT)vs › | $319.69M | 3.87 | 3.84 | 4.42 | 6.10 |
| Avita Medical Inc. (RCEL)vs › | $319.85M | 0.34 | 1.47 | 4.59 | 7.40 |
| Sanara MedTech Inc. (SMTI)vs › | $321.44M | 2.30 | 1.79 | 1.49 | 1.77 |
| Agenus Inc. (AGEN)vs › | $323.77M | 0.34 | 0.31 | 0.53 | 0.83 |
| CapsoVision, Inc. (CV)vs › | $323.87M | 2.44 | 4.94 | 7.05 | 7.05 |
| C4 Therapeutics, Inc. (CCCC)vs › | $311.49M | 5.45 | 6.76 | 6.92 | 7.12 |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $303.06M | 12.80 | 4.01 | 4.01 | 4.01 |
| Benitec Biopharma Inc. (BNTC)vs › | $302.14M | 34.00 | 44.34 | 25.02 | 19.51 |
| Relmada Therapeutics, Inc. (RLMD)vs › | $347.71M | 29.52 | 9.54 | 9.83 | 10.59 |
Quick Ratio
5.79
Excludes inventory
Current Ratio
5.79
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 5.79 |
| 2026-03-31 | 2.95 |
| 2025-12-31 | 2.77 |
| 2025-09-30 | 3.60 |
| 2025-06-30 | 4.78 |
| 2025-03-31 | 3.96 |
| 2024-12-31 | 6.15 |
| 2024-09-30 | 8.11 |
| 2024-06-30 | 11.52 |
| 2024-03-31 | 12.66 |
| 2023-12-31 | 15.29 |
| 2023-09-30 | 15.65 |
| 2023-06-30 | 20.94 |
| 2023-03-31 | 10.29 |
| 2022-12-31 | 11.47 |
| 2022-09-30 | 15.20 |
| 2022-06-30 | 15.22 |
| 2022-03-31 | 16.07 |
| 2021-12-31 | 14.86 |
| 2021-09-30 | 20.07 |
| 2021-06-30 | 18.75 |
| 2021-03-31 | 26.65 |
| 2020-12-31 | 21.92 |
| 2020-09-30 | 27.95 |
| 2020-06-30 | 37.84 |
| 2020-03-31 | 41.19 |
| 2019-12-31 | 44.66 |
| 2019-09-30 | 23.42 |
| 2019-06-30 | 40.68 |
| 2019-03-31 | 0.00 |
| 2018-12-31 | 36.05 |
| 2018-09-30 | 0.00 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 0.00 |
